poisar

Stocks · News reference

Aethlon Medical Pivots to Biotechnology with All-Stock Merger

BenzingaVandana Singh

Aethlon Medical merges with North Immunology in an all-stock transaction to trade on Nasdaq as NRTX with $180 million in funding.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading